Lv22
190 积分 2023-05-13 加入
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
24天前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
24天前
已完结
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
24天前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
24天前
已完结
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
24天前
已完结
Efficacy and Safety of Ca2+ Channel α2δ Ligands for the Treatment of Diabetic Peripheral Neuropathic Pain: A Systematic Review and Network Meta-analysis
1个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors
1个月前
已完结
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
1个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
1个月前
已完结
皖公网安备34019202002308
